Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by PTK6 is a cytoplasmic nonreceptor protein kinase which may function as an intracellular signal transducer in epithelial tissues. Additionally we are shipping PTK6 Proteins (15) and PTK6 Kits (11) and many more products for this protein.
Showing 10 out of 157 products:
Human Polyclonal PTK6 Primary Antibody for IF, WB - ABIN519483
Foudah, Sallam, Akl, El Sayed: Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors. in European journal of medicinal chemistry 2014
Show all 3 Pubmed References
Human Monoclonal PTK6 Primary Antibody for IHC (p), ELISA - ABIN519484
Akl, Ayoub, Mohyeldin, Busnena, Foudah, Liu, Sayed: Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models. in PLoS ONE 2014
Show all 2 Pubmed References
Human Monoclonal PTK6 Primary Antibody for ELISA, WB - ABIN2869234
Liu, Zhang, Zhong, Li, Liu, Lin, Wu, Zeng: Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma. in Journal of translational medicine 2013
Human Polyclonal PTK6 Primary Antibody for IHC (p), WB - ABIN392105
Derry, Prins, Ray, Tyner: Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells. in Oncogene 2003
Show all 2 Pubmed References
Human Polyclonal PTK6 Primary Antibody for IF (p), IHC (p) - ABIN1713614
Akl, Foudah, Ebrahim, Meyer, El Sayed: The marine-derived sipholenol A-4-O-3',4'-dichlorobenzoate inhibits breast cancer growth and motility in vitro and in vivo through the suppression of Brk and FAK signaling. in Marine drugs 2014
Human Monoclonal PTK6 Primary Antibody for ELISA - ABIN966923
Ottilie, Raulf, Barnekow, Hannig, Schartl: Multiple src-related kinase genes, srk1-4, in the fresh water sponge Spongilla lacustris. in Oncogene 1992
Show all 3 Pubmed References
Human Monoclonal PTK6 Primary Antibody for ELISA, WB - ABIN969373
Wilks: Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. in Proceedings of the National Academy of Sciences of the United States of America 1989
Show all 4 Pubmed References
Expression of PTK6 in established tumors may maintain the epithelial phenotype, preventing tumor progression.
analysis of recombinant PTK6 kinase domain by x-ray crystallography reveals details of its binding to inhibitors
The crystal structure of the kinase domain of human PTK6 has been reported.
PTK6 mRNA and protein levels were elevated in cervical squamous cell cancer and the elevated cytoplasmic expression of PTK6 was associated with tumor grade and short patient survival.
PELP1 (show PELP1 Antibodies) interacted with GR to activate Brk expression.
PTK6 prolongs S-phase and increases the ability of gemcitabine to cause DNA damage in vitro and in vivo
BRK expression in a majority of CC can interact with RTK, augmenting growth and interfering with proliferation inhibitors (SAM68 (show KHDRBS1 Antibodies)). Therapeutically targeting BRK function (in addition to RTK) should be of benefit for CC treatment.
Additive impact of HER2 (show ERBB2 Antibodies)-/PTK6-RNAi on interactions with HER3 (show ERBB3 Antibodies) or IGF-1R (show IGF1R Antibodies) leads to reduced breast cancer progression
overexpression or knockdown of PTK6 or ERK1/2 effectively removed the inhibition of S1P-induced migration by miR-17.
Establishment of cross talk between PTK6 and CagA (show S100A8 Antibodies) by functional studies may further elucidate the underlying biology of H. pylori-mediated gastric cancer
PTK6 may act as a novel mediator of TNFalpha (show TNF Antibodies)/IFNgamma intestinal epithelial permeability during inflammatory injury, and miR (show MLXIP Antibodies)-93 may protect intestinal epithelial barrier function, at least in part, by targeting PTK6
Ptk6 promotes ERBB2 (show ERBB2 Antibodies)-induced mammary gland tumorigenesis in the mouse.
Protein tyrosine kinase 6 has a role in mediating TNFalpha (show TNF Antibodies)-induced endothelial barrier dysfunction
Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT (show AKT1 Antibodies).
expression of Brk/PTK6 in non-transformed mammary epithelial cells mediates p38 MAPK (show MAPK14 Antibodies) phosphorylation and promotes increased cellular survival, delayed involution, and latent tumor formation.
a novel function for PTK6 at the plasma membrane
PTK6 promotes STAT3 (show STAT3 Antibodies) activation in the colon following injection of the carcinogen azoxymethane and regulates STAT3 (show STAT3 Antibodies) activity in mouse colon tumors.
AKT (show AKT1 Antibodies) is a direct substrate of PTK6 and AKT (show AKT1 Antibodies) tyrosine residues 315 and 326 are phosphorylated by PTK6.
PTK6 associates with nuclear and cytoplasmic beta-catenin (show CTNNB1 Antibodies) and inhibits beta-catenin (show CTNNB1 Antibodies)- and T-cell factor (TCF (show HNF4A Antibodies))-mediated transcription.
The protein encoded by this gene is a cytoplasmic nonreceptor protein kinase which may function as an intracellular signal transducer in epithelial tissues. Overexpression of this gene in mammary epithelial cells leads to sensitization of the cells to epidermal growth factor and results in a partially transformed phenotype. Expression of this gene has been detected at low levels in some breast tumors but not in normal breast tissue. The encoded protein has been shown to undergo autophosphorylation. Alternative splicing results in multiple transcript variants.
PTK6 protein tyrosine kinase 6
, protein-tyrosine kinase 6-like
, breast tumor kinase
, protein-tyrosine kinase 6
, protein-tyrosine kinase BRK
, tyrosine-protein kinase BRK
, protein tyrosine kinase 6
, src-related intestinal kinase
, tyrosine kinase identified from skin